A carregar...
Stem cell persistence in chronic myeloid leukemia
Tyrosine kinase inhibitors (TKIs) of BCR-ABL have turned chronic myeloid leukemia (CML) from a deadly disease into a chronic ailment. Unfortunately, evidence is accumulating that TKIs are not curative, since CML stem cells are not addicted to BCR-ABL, and persist despite TKI therapy. On closer view...
Na minha lista:
| Publicado no: | Leukemia Suppl |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4851205/ https://ncbi.nlm.nih.gov/pubmed/27175248 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leusup.2012.24 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|